SEK 3.06
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -10.48 Million SEK | -42.64% |
2022 | -7.35 Million SEK | 5.75% |
2021 | -7.79 Million SEK | -289.36% |
2020 | 4.11 Million SEK | -34.42% |
2019 | 6.27 Million SEK | 9.95% |
2018 | 5.71 Million SEK | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q3 | 3.13 Million SEK | 1481.5% |
2024 Q2 | -227 Thousand SEK | 60.52% |
2024 Q1 | -575 Thousand SEK | 93.95% |
2023 Q3 | 597 Thousand SEK | 145.16% |
2023 FY | -10.48 Million SEK | -42.64% |
2023 Q4 | -9.5 Million SEK | -1691.62% |
2023 Q2 | -1.32 Million SEK | -2032.26% |
2023 Q1 | -62 Thousand SEK | 96.19% |
2022 Q3 | 945 Thousand SEK | 129.38% |
2022 Q2 | -3.21 Million SEK | 19.44% |
2022 Q1 | -3.99 Million SEK | 50.92% |
2022 FY | -7.35 Million SEK | 5.75% |
2022 Q4 | -1.62 Million SEK | -272.38% |
2021 FY | -7.79 Million SEK | -289.36% |
2021 Q4 | -8.13 Million SEK | -1336.02% |
2021 Q3 | 658 Thousand SEK | -1.79% |
2021 Q2 | 670 Thousand SEK | 157.36% |
2021 Q1 | -1.16 Million SEK | -35.19% |
2020 FY | 4.11 Million SEK | -34.42% |
2020 Q4 | -864 Thousand SEK | 0.0% |
2020 Q3 | -864 Thousand SEK | -138.93% |
2020 Q2 | 2.21 Million SEK | 0.0% |
2020 Q1 | 2.21 Million SEK | 0.0% |
2019 FY | 6.27 Million SEK | 9.95% |
2018 FY | 5.71 Million SEK | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aino Health AB (publ) | -9.51 Million SEK | -10.207% |
Bonzun AB (publ) | -25.25 Million SEK | 58.487% |
Kontigo Care AB (publ) | 52 Thousand SEK | 20261.538% |
RaySearch Laboratories AB (publ) | 114.88 Million SEK | 109.126% |
Surgical Science Sweden AB (publ) | 191.28 Million SEK | 105.481% |